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Abstract
Focal adhesion assembly and disassembly are essential for cell migration and cancer invasion, but the detailed molecular
mechanisms regulating these processes remain to be elucidated. Phosphatidylinositol phosphate kinase type Ic (PIPKIc)
binds talin and is required for focal adhesion formation in EGF-stimulated cells, but its role in regulating focal adhesion
dynamics and cancer invasion is poorly understood. We show here that overexpression of PIPKIc promoted focal adhesion
formation, whereas cells expressing either PIPKIcK188,200R or PIPKIcD316K, two kinase-dead mutants, had much fewer focal
adhesions than those expressing WT PIPKIc in CHO-K1 cells and HCT116 colon cancer cells. Furthermore, overexpression of
PIPKIc, but not PIPKIcK188,200R, resulted in an increase in both focal adhesion assembly and disassembly rates. Depletion of
PIPKIc by using shRNA strongly inhibited formation of focal adhesions in HCT116 cells. Overexpression of PIPKIcK188,200R or
depletion of PIPKIc reduced the strength of HCT116 cell adhesion to fibronection and inhibited the invasive capacities of
HCT116 cells. PIPKIc depletion reduced PIP2 levels to ,40% of control and PIP3 to undetectable levels, and inhibited vinculin
localizing to focal adhesions. Taken together, PIPKIc positively regulates focal adhesion dynamics and cancer invasion, most
probably through PIP2-mediated vinculin activation.
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Introduction
Focal adhesions (FAs, also called cell-matrix adhesions) are
specific types of large macromolecular assemblies at the ventral
surface of cells, functioning as both mechanical machineries and
regulatory signaling hubs [1,2]. Temporal and spatial regulation of
focal adhesion assembly/disassembly is required for cell migration
[3]. During cell migration, nascent focal adhesions (also called
focal complexes) are formed to stabilize lamellipodia at the front of
cells while focal adhesions are dissolved at the trailing edges of cells
[4,5].
Focal adhesion assembly and disassembly are also implicated in
cancer invasion, a prerequisite for metastasis. DRR (Down-
Regulated in Renal cell carcinoma) associates with actin and
microtubules and stimulates glioma invasion by promoting focal
adhesion disassembly [6]. The actin cross-linking protein filamin A
suppresses focal adhesion disassembly and breast cancer cell
invasion [7]. Rho/Rock signaling promotes tumor cell migration
and invasion by regulating focal adhesion dynamics through
caveolin-1 phosphorylation [8]. FAK also promotes focal adhesion
disassembly and cancer invasion [9,10,11]. Focal adhesion
dynamics and signaling pathways that regulate this process could
be therefore an attractive target for cancer therapy.
Many molecules have been shown to regulate focal adhesion
dynamics. FAK regulates focal adhesion turnover [9,12], probably
through a dynamin and microtubule-dependent pathway [13].
Paxillin, a focal adhesion adaptor, also modulates focal adhesion
dynamics by JNK and PAK-mediated phosphorylation [14,15].
Talin activates integrins and initiates focal adhesion formation
[16,17,18], whereas cleavage of talin by calpain mediates focal
adhesion disassembly [19]. Calpain also cleaves FAK and paxillin
to modulate focal adhesion dynamics [20,21]. We have shown that
Smurf1-mediated ubiquitination of the talin head domain, one of
the two cleavage products, plays an important role in focal
adhesion disassembly and cell migration [22]. ACF7, a microtu-
bule and filamentous actin binding protein, regulates focal
adhesion assembly/disassembly through its ATPase activity [23].
However, the molecular mechanisms that control focal adhesion
assembly/disassembly are not fully understood.
Phosphatidylinositol phosphate kinase type I c (PIPKIc) is an
enzyme that catalyzes ATP-dependent phosphorylation of phos-
phatidylinositol 4-phosphate (PI(4)P) to generate PI(4,5)P2, which
regulates a variety of biological processes, including focal adhe-
sion formation [24]. PIPKIc has a well-conserved kinase catalytic
domain at the central region [25]. Within the catalytic domain,
there is a subdomain called the activation loop, which determines
site of phosphorylation on the inositol ring of the substrate.
PIPKIc strongly interacts with talin and competes for talin binding
with the b integrin tail [26,27]. It is localized at adherens junctions
in epithelial cells [28,29]. It has been reported that PIPKIc is
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required for focal adhesion formation in migratory cells [30].
However, the precise roles of the lipid kinase activities of PIPKIc
in focal adhesion dynamics are not defined.
In the present study, we investigated the requirement for the
lipid kinase activity of PIPKIc in focal adhesion dynamics and
colon cancer invasion. Our results identify an essential role of
PIPKIc in focal adhesion assembly/disassembly and cancer
invasion.
Results
PIPKIc promotes focal adhesion formation
To examine a possible role for PIPKIc in focal adhesion
formation, CHO-K1 cells were transfected with EGFP-PIPKIc or
EGFP vector, respectively. The cells were re-plated on fibronectin,
fixed with paraformaldehyde, incubated with an anti-paxillin
monoclonal antibody, and then stained with Dylight 549
conjugated goat anti-mouse IgG. Focal adhesions were lined up
around the edges of the EGFP vector-transfected cells, with few
focal adhesions in the centers of the cells, whereas PIPKIc
expression dramatically stimulated focal adhesion formation in the
centers of the cells (Fig. 1A). Over-expression of PIPKIc stimulates
an increase in focal adhesion numbers (Fig. 1B) and the increase
was mainly contributed by small focal adhesions (,3 mm2)
(Fig. 1C). The stimulation of focal adhesion formation by PIPKIc
relies on its interaction with talin, because PIPKIcW647F, a mutant
that is deficient in the interaction with talin, was not able to
promote focal adhesion formation (Fig. 1A, B, & C).
PIPKIc kinase activity is required for stimulation of focal
adhesion formation
PI(4,5)P2 binds talin and strengthens the interaction between
talin and the b integrin tail, stimulating integrin clustering [31].
PI(4,5)P2 also binds vinculin and unmasks the actin and talin
binding sites on vinculin, promoting focal adhesion formation
[32]. Therefore, PIPKIc-stimulated PI(4,5)P2 synthesis could be
essential for promoting focal adhesion formation. To test this
hypothesis, we mutated two lysine residues, K188 and K200, to
arginine residues within the ATP-binding site of PIPKIc. The
mutant PIPKIcK188,200R and the WT were purified from CHO-
K1 cells and the kinase activities were examined in vitro by using
mass spectrometry to quantitate production of PI(4,5)P2 from
PI(4)P. As shown in Fig. 2A, mutation at K188 and K200 reduced
kinase activity by 95%. EGFP-tagged mutant PIPKIcK188,200R
and WT PIPKIc were stably expressed in CHO-K1 cells, and
their effects on focal adhesion formation were examined after
paxillin staining. Cells that stably express WT PIPKIc formed
focal adhesions around the edges and in the centers of cells,
whereas cells that express PIPKIcK188,200R, similar to parental
cells, possessed small focal adhesions, most of which were around
the edges of the cells, and had a defect in spreading (Fig. 2B).
Quantitative analysis indicated that PIPKIc increased focal
adhesions by more than 2 fold, whereas PIPKIcK188,200R did not
significantly promote focal adhesion formation (Fig. 2C&D). These
results indicate that PIPKIc activity is essential for focal adhesion
formation in CHO-K1 cells.
To further verify the requirement of PIPKIc activity for focal
adhesion formation, we tested the capacity of another kinase dead
mutant, PIPKIcD316K [33], to promote focal adhesion formation
as described above. As shown in Fig. S1, the average focal
adhesion number (per cell) in cells expressing PIPKIcD316K was
approximately 45, which is approximately the same as that in cells
expressing EGFP vector (Fig. 1). The focal adhesions in cells
expressing PIPKIcD316K accumulated at the edges of the cells,
with very few focal adhesions in the center of the cells. This result
confirms the essential role of PIPKIc activity in focal adhesion
formation.
The activity of PIPKIc is essential for its promoting focal
adhesion dynamics
To examine whether PIPKIc lipid kinase activity is required for
focal adhesion dynamics, CHO-K1 cells that stably express EGFP-
PIPKIc or -PIPKIcK188,200R were transfected with mDsRed-
paxillin and then plated on MatTek dishes (with a glass coverslip at
the bottom) precoated with fibronectin (5 mg/ml) and grown for
3 hr. TIRF images of mDsRed-paxillin were taken using a Nikon
TIRF microscope and the temperature was maintained at 37uC
using an INU-TIZ-F1 microscope incubation system (Tokai Hit).
Images were recorded at 1-min intervals for a 120 min period.
Focal adhesion assembly and disassembly rate constants were
calculated as described previously [22]. The FA assembly and
disassembly rate constants in cells expressing PIPKIcK188,200R
were 0.08360.014 and 0.07260.010 min21, respectively, which
are similar to those in normal CHO-K1 cells that we reported
previously [22], whereas FA assembly and disassembly rate
constants were 0.19060.019 and 0.13660.014 min21, respective-
ly, in cells expressing WT PIPKIc (Fig. 3). This result indicates
that the inositol lipid kinase activity of PIPKIc is required for its
stimulation of focal adhesion assembly and disassembly.
An essential role for PIPKIc in focal adhesion formation in
colon cancer cells
Focal adhesions have been implicated in regulating cancer
invasion, while the role of focal adhesions in colon cancer cells has
not been well defined. To determine if the activity of PIPKIc
influences focal adhesion formation in colon cancer cells, HCT116
cells that stably express EGFP-PIPKIc or -PIPKIcK188,200R were
plated on fibronectin and stained for paxillin. As shown in Fig. 4A,
most of the focal adhesions were located to the peripheral region,
and HCT116 cells expressing PIPKIcK188,200R had much fewer
focal adhesions than those expressing the WT enzyme. The
average focal adhesion number in cells expressing WT PIPKIc
was 22.5/cell, whereas that in cells expressing PIPKIcK188,200R
was 11.5/cell, both of which were fewer than those observed in
CHO-K1 cells (Fig. 4B). In addition, PIPKIcK188,200R had more
effect on the smaller focal adhesions than the larger ones (Fig. 4C).
To test whether PIPKIc is essential for focal adhesion formation
in HCT116 cells, HCT116 cells were infected with recombinant
lentiviruses that express PIPKIc shRNA or shRNA control and
were selected with puromycin. As shown in Fig. 5A, expression of
PIPKIc shRNA resulted in dramatic reduction in the endogenous
PIPKIc level of HCT116 cells. The cells were then plated on
fibronectin and stained for paxillin. Surprisingly, PIPKIc knock-
down almost abolished focal adhesion formation in HCT116 cells
(Fig. 5B). PIPKIc depletion reduced focal adhesion number by
about 74% (Fig. 5C). Different from PIPKIcK188,200R, PIPKIc
shRNA had more effect on the larger focal adhesions than the
smaller ones (Fig. 5D). These results indicate an essential role of
PIPKIc in focal adhesion formation in HCT116 colon cancer cells.
This dramatic effect of PIPKIc knockdown did not occur in MDA-
MB-231 human breast cancer cells, where PIPKIc knockdown only
partially inhibited focal adhesion formation (data not shown).
PIPKIc positively modulates adhesion strength of colon
cancer cells to fibronectin
To examine whether the activity of PIPKIc regulates cell
adhesion strength on fibronectin, HCT116 cells that stably express
PIPKIc in Focal Adhesions and Cancer Invasion
PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e24775
EGFP-PIPKIc or -PIPKIcK188,200R were stained with calcein-AM
and seeded on a 96-well plate that was pre-coated with different
concentrations of fibronectin. The calcein fluorescence was read,
and then the plate was inverted and centrifuged at 1506g for
5 min. The calcein fluorescence was read again. As shown in
Fig. 6A, the cell adhesion strength difference between the cells
expressing PIPKIcK188,200R and the WT was not significant at
high concentrations of fibronection. However, at low concentra-
tions of fibronectin, the cells expressing PIPKIcK188,200R had
significantly lower adhesion strength as compared to those
expressing the WT. PIPKIc knockdown also caused a significant
decrease in cell adhesion strength in HCT116 cells (Fig. 6B).
These results indicate that PIPKIc activity regulates cell adhesion
strength in colon cancer cells.
PIPKIc is essential for invasion but not the migration of
colon cancer cells
It has been reported that PIPKIc plays a role in cell migration.
To test whether PIPKIc regulates the migration of HCT116 colon
cancer cells, we employed time-lapsed wound-healing assays to
examine the migration of HCT116 cells expressing EGFP-PIPKIc
and –PIPKIcK188,200R, respectively, in the presence of HGF. As
shown in Fig. S2 A&B, cells expressing PIPKIcK188,200R migrated
slightly faster than those expressing the WT enzyme as measured
Figure 1. PIPKIc promoted focal adhesion formation in CHO-K1 cells. (A) TIRF images of CHO-K1 cells expressing EGFP, EGFP-PIPKIc WT or
EGFP-PIPKIcW647F. Cells were transiently transfected with pEGFP-vector, -PIPKIc WT or -PIPKIcW647F, and then stained for paxillin. Scale bar, 20 mm. (B)
Expression of PIPKIc but not PIPKIcW647F caused an increase in focal adhesion number (n = 15, error bar = mean 6 s.e.m; Vector vs WT, P,0.001; WT vs
W647F, P,0.001; Vector vs W647F, P.0.05). (C) Area distribution of focal adhesions in cells expressing EGFP, EGFP-PIPKIc WT or EGFP-PIPKIcW647F.
doi:10.1371/journal.pone.0024775.g001
PIPKIc in Focal Adhesions and Cancer Invasion
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by time-lapse wound-healing assays. Also, depletion of PIPKIc
had no significant effect on the migration of HCT116 cells in
transwell assays (Fig. S2 C&D). These results suggest that PIPKIc
activity is not essential for the migration of HCT116 colon cancer
cells.
To test the role of PIPKIc in cancer invasion, the invasion of
HCT116 cells that stably express PIPKIc shRNA or a shRNA
control in the absence and presence of HGF was examined by
using Matrigel invasion assays. As shown in Fig. 7 (A&B), PIPKIc
knockdown resulted in significant reduction in the invasion of
HCT116 cells either in the absence or in the presence of HGF.
The basal and HGF-stimulated invasive capacities of HCT116
cells stably expressing PIPKIcK188,200R are also significantly lower
than those of the cells expressing the WT enzyme (Fig. 7C&D).
These results indicate that PIPKIc positively regulates the invasion
of HCT116 colon cancer cells.
Figure 2. Mutation at the kinase domain of PIPKIc abolished its activity and ability to promote focal adhesion formation in CHO-K1
cells. (A) Analysis of the activities of PIPKIc and PIPKIcK188,200R. (B) TIRF images of CHO-K1 cells that express PIPKIc or PIPKIcK188,200R and the parental
CHO-K1 cells. The parental cells and cells expressing EGFP-PIPKIc WT or -PIPKIcK188, 200R were stained for paxillin. Scale bar, 20 mm. (C) Quantitative
analysis of focal adhesion numbers (per cell) in the parental cells and cells that express PIPKIc or PIPKIcK188,200R (n = 30, error bar = mean 6 s.e.m;
parental vs PIPKIc, P,0.001; parental vs PIPKIcK188,200R, P.0.05). (D) Area distribution of focal adhesions in the parental cells and cells expressing
PIPKIc and PIPKIcK188,200R.
doi:10.1371/journal.pone.0024775.g002
PIPKIc in Focal Adhesions and Cancer Invasion
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PIPKIc regulates focal adhesion formation through
activating vinculin by PI(4,5)P2
To dissect the mechanism by which PIPKIc regulates focal
adhesion formation, we set out to analyze the levels of polypho-
sphoinositides in HCT116 cells that express PIPKIc shRNA or a
shRNA control by using mass spectrometry. Depletion of PIPKIc
in HCT116 cells had no significant effect on the level of PIP, but
caused significant reduction in PIP2 level (note that these methods
cannot distinguish positional enantiomers of these lipids so it is
possible that PI(3,4)P2 may contribute significantly to residual
levels of PIP2 in these cells). Interestingly, in support of this idea
knockdown of PIPKIc reduced PIP3 levels below the detection
limit of our assay (Fig. 8). These results indicate that PIPKIc is a
key enzyme responsible for the production of PI(4,5)P2 and
PI(3,4,5)P3 in HCT116 cells.
To see whether PI(3,4,5)P3 is essential for focal adhesion
formation in colon cancer cells, HCT116 cells were treated
with LY294002, a specific inhibitor of phosphatidylinositol
3-kinase, and focal adhesion formation in these cells was
examined after paxillin staining. LY294002 (20 mM) had no
significant effect on focal adhesion formation (data not shown).
Taken together with the above observations, this finding
indicates that PI(4,5)P2, but not PI(3,4,5)P3, is required for
focal adhesion formation.
Figure 3. PIPKIc WT but not PIPKIcK188,200R promoted focal adhesion assembly and disassembly in CHO-K1 cells. (A) CHO-K1 cells
stably expressing PIPKIc or PIPKIcK188,200R were transiently transfected with mDsRed-paxillin. The cells were plated on fibronectin and the dynamics of
paxillin was analysed using time-lapse TIRF microscopy. Arrowheads point to dynamic (upper panels) and stable (lower panels) focal adhesions. (B)
The overlay of 0 and 24 min in ‘‘A’’. (C) Quantification of the focal adhesion assembly and disassembly rate constants in cells that express PIPKIc
or PIPKIcK188,200R. Quantifications are expressed as mean 6 s.e.m. of 50 focal adhesions from 10 cells. Assembly, WT vs K188,200R, P,0.00005;
disassembly, p,0.005.
doi:10.1371/journal.pone.0024775.g003
PIPKIc in Focal Adhesions and Cancer Invasion
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PI(4,5)P2 binds and activates vinculin and is implicated in
regulating focal adhesion formation [32]. If PIPKIc-mediated
production of PI(4,5)P2 is essential for focal adhesion formation in
HCT116 cells, depletion of PIPKIc would reduce PI(4,5)P2 levels
and prevent vinculin from localizing to focal adhesions. To test this
hypothesis, endogenous PIPKIc-depleted cells were infected with
retroviruses expressing a codon-modified PIPKIc (rescue) (Fig. 9A),
and the cells were stained for vinculin. Vinculin was rarely
localized to focal adhesions in PIPKIc-depleted HCT116 cells,
whereas re-expression of PIPKIc in PIPKIc-depleted cells resulted
in a dramatic increase in focal adhesion-localized vinculin (Fig. 9B).
Quantitative analysis indicated that PIPKIc rescue restored focal
adhesion formation in PIPKIc-depleted cells (Fig. 9C&D), as
compared to the data in Fig. 5. These data suggest that PIPKIc
may regulate focal adhesion formation through PI(4,5)P2-mediated
vinculin activation.
Figure 4. PIPKIcK188,200R was incapable of mediating focal adhesion formation in HCT116 cells. (A) TIRF images of CHO-K1 cells
expressing PIPKIc or PIPKIcK188,200R. Cells that stably express EGFP-PIPKIc WT or -PIPKIcK188, 200R were stained for paxillin. Scale bar, 20 mm. (B)
PIPKIcK188, 200R failed to stimulate an increase in focal adhesion number (n = 10, error bar = mean 6 s.e.m; paired t-test, P,0.005). (C) Area distribution
of focal adhesions in cells expressing PIPKIc and PIPKIcK188,200R.
doi:10.1371/journal.pone.0024775.g004
PIPKIc in Focal Adhesions and Cancer Invasion
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Discussion
Besides serving as the precursor of other second messengers,
PI(4,5)P2 itself binds many cytoskeletal and focal adhesion proteins
and is believed to be a key regulator of focal adhesion dynamics
[34]. PI(4,5)P2 binds vinculin to unmask the talin-binding sites on
vinculin [32]; it also binds talin thus stabilizing talin-integrin
interactions [35]. PIPKIc is thought to be the enzyme that
generates PI(4,5)P2 spatially and temporally for focal adhesion
formation during cell migration [27,34]. On the other hand,
PI(4,5)P2 has not been detected at focal adhesions and the role of
PIPKIc in regulating focal adhesion dynamics is controversial
[36]. PIPKIc has been shown to be required for focal adhesion
formation during EGF-stimulated cell migration [30], whereas it
has also been reported that expression of PIPKIc caused cell
rounding and focal adhesion disassembly [26].
We show here that expression of PIPKIc at low levels in CHO-K1
cells stimulated focal adhesion formation (Fig. 1), whereas kinase-dead
mutants, PIPKIcK188,200R and PIPKIcD316K failed to promote focal
adhesion formation (Fig. 2, Fig. 4 and Fig. S1). Furthermore, PIPKIc
knockdown almost completely abolished focal adhesion formation in
HCT116 colon cancer cells (Fig. 5). In addition, expression of PIPKIc
promoted focal adhesion assembly and also disassembly rates, while
PIPKIcK188,200R was unable to do so (Fig. 3). These results identify an
essential role of PIPKIc in regulating focal adhesion dynamics.
Although direct evidence is lacking, PI(4,5)P2 has been well
implicated in regulating integrin activation. PI(4,5)P2 binds talin
and blocks its self-inhibition (head-tail interaction) thus promoting
its interaction with the b integrin tail [35]. It also stimulates
integrin clustering [31]. The increase in both talin-integrin
interaction and integrin clustering should stimulate integrin
activation. We found that HCT116 cells expressing PIP-
KIcK188,200R have significantly lower adhesion strength as
compared to those expressing the WT, and depletion of PIPKIc
by shRNA also caused a significant decrease in cell adhesion
strength in HCT116 cells (Fig. 6), suggesting that PIPKIc may
modulate integrin activation in colon cancer cells.
It has been reported that PIPKIc is required for EGF-
stimulated migration of MDA-MB-231 human breast cancer cells
and HeLa human ovarian cancer cells [30,37]. However, our
results here show that neither expressing PIPKIcK188,200R, a
kinase-dead mutant, nor depletion of PIPKIc inhibit the migration
of HCT116 cells (Fig. S2). The MDA-MB-231 and HeLa cells
migrate much faster than HCT116 cells, suggesting that PIPKIc is
essential for fast-moving cells, but not for slow-migrating cells like
HCT116 cells. This is supported by our unpublished result that
PIPKIcK188,200R dramatically inhibits the migration of Clone A
cells, a fast-moving colon cancer cell line.
On the other hand, PIPKIc seems to be required for the
invasion of both fast- (such as MDA-MB-231) and slow-invading
Figure 5. PIPKIc is essential for focal adhesion formation in HCT116 cells. (A) Expression of PIPKIc in cells stably expressing shRNA control
and PIPKIc shRNA. (B) TIRF images of HCT116 cells that stably express control and PIPKIc shRNA. Cells were infected with lentiviral particles carrying
control or PIPKIc shRNA, selected with puromycin, and stained for paxillin. Scale bar, 20 mm. (C) PIPKIc depletion inhibited focal adhesion formation in
HCT116 cells. (n = 10, error bar = mean 6 s.e.m; paired t-test, P,0.0001) (D) Area distribution of focal adhesions in cells expressing control and PIPKIc
shRNA.
doi:10.1371/journal.pone.0024775.g005
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(such as HCT116) cancer cells. Depletion of PIPKIc has been
shown to inhibit EGF-stimulated invasion of MDA-MB-231 cells
[37], and either expressing PIPKIcK188,200R or the depletion of
PIPKIc inhibits the invasion of HCT116 cells (Fig. 7). These
results indicate an essential role of PIPKIc in controlling cancer
invasion.
Previous studies have focused on the role of focal adhesion
disassembly in regulating cancer invasion. DRR promotes glioma
invasion by promoting focal adhesion disassembly [6]. Filamin A
suppresses breast cancer cell invasion by inhibiting focal adhesion
disassembly [7]. FAK also promotes focal adhesion disassembly
and cancer invasion [9]. However, our results show that both
expression of PIPKIcK188,200R, the kinase-dead mutant, and
depletion of PIPKIc impair focal adhesion formation, accompa-
nying the inhibition of the invasion of HCT116 (Fig. 4, 5 and 7).
In addition, PIPKIc stimulates both focal adhesion assembly and
disassembly (Fig. 3), suggesting that focal adhesion turnover, which
requires focal adhesion assembly and disassembly spatially and
temporarily, regulates the invasion of cancer cells.
PIPKIc is a major enzyme that controls polyphosphoinositide
metabolism in HCT116 cells. PIPKIc knockdown results in
significant reduction in the level of PI(4,5)P2 and decreases
PI(3,4,5)P3 levels even more substantially (Fig. 8). PI(3,4,5)P3
plays an important role in tumorigenesis and cancer metastasis.
However, PIPKIc knockdown does not affect the activation of
Akt, a major target of PI(3,4,5)P3, in HCT116 cells (data not
shown), probably because Akt can be activated by PI(3,4)P2, which
is not directly affected by PIPKIc.
Inhibition of PI 3-kinase using LY294002 does not influence focal
adhesion formation in HCT116 cells, suggesting that PI(4,5)P2
instead of PI(3,4,5)P3 is responsible for PIPKIc-mediated focal
adhesion formation. PI(4,5)P2 promotes vinculin binding to talin
and actin and has been shown to be essential for focal adhesion
formation [32]. Our result shows that PIPKIc regulates vinculin
localizing to focal adhesions in HCT116 cells (Fig. 9). Taken
together, it is most likely that PIPKIc regulates focal adhesion
formation through PI(4,5)P2-mediated vinculin activation.
Cancer invasion is a complicated process, requiring spatial and
temporary regulation of cell-matrix adhesions, cell protrusions and
matrix-degradation [38]. PI(4,5)P2 generated by PIPKIc regulates
cancer invasion through modulating cell adhesion dynamics.
Although PI(3,4,5)P3 is not essential for focal adhesion formation,
it may also play a role in other aspects of cancer invasion, probably
through activating Rac [39].
Materials and Methods
Reagents
Anti-paxillin antibody (clone 5H11) was from Millipore; Anti-
PIPKIc polyclonal antibody was from Cell Signaling Technology;
Anti-tubulin antibody and pLKO1 lentivirus PIPKIc shRNA
(sequence: CCG GGC AGT CCT ACA GGT TCA TCA ACT
CGA GTT GAT GAA CCT GTA GGA CTG CTT TTT G)
were from Sigma; DyLight 549 conjugated goat anti-mouse IgG
(H+L) was from Thermo Scientific; Fibronectin and recombinant
HGF were from Akron Biotech; Growth factor reduced Matrigel
was from BD Bioscience; The plasmid pEGFP-PIPKIc was a gift
from Dr. Mark Ginsberg (University of California-San Diego); Pfu
Ultra was from Agilent Technologies; DNA primers were
synthesized by Integrated DNA Technologies.
Plasmid construction
The plasmid pEGFP-PIPKIcW647F was generated by pfu Ultra-
based PCR using pEGFP-PIPKIc as template and 59-GAT GAG
AGG AGC TTT GTG TAC TCC CCG CTC-39/59-GAG CGG
GGA GTA CAC AAA GCT CCT CTC ATC-39 as primers.
pEGFP-PIPKIcK188,200R and pZZ-PIPKIcK188,200R were created
by PCR using pEGFP-PIPKIc and pZZ-PIPKIc [40] as
templates, respectively, and sequentially 59-GAC GAG TTC
ATC ATC AGG ACC GTC ATG CAC-39/59-GTG CAT GAC
GGT CCT GAT GAT GAA CTC GTC-39 and 59-GTT CCT
GCA GAG GCT GCT CCC TGG CTA C-39/ 59-GTA GCC
AGG GAG CAG CCT CTG CAG GAA C-39 as primers.
pEGFP-PIPKIcD316K was constructed by using pEGFP-PIPKIc as
template and 59-AGT TTC AAG ATC ATG AAG TAC AGC
CTG CTG CTG GGC-39/59-GCC CAG CAG CAG GCT GTA
CTT CAT GAT CTT GAA ACT-39 as primers. pBabe-EGFP-
PIPKIc and -EGFP-PIPKIcK188,200R were generated by sequen-
tially digesting pEGFP- PIPKIc and pEGFP-PIPKIcK188,200R with
Age1, treating with Klenow and digesting with Sal1. The
Resulting smaller fragments were subcloned into pBabe-puro
vector that had been pre-treated with EcoR1, Klenow and Sal1.
pBabe-ZZ-PIPKIc was made by sequentially digesting pZZ-
Figure 6. Either expression of PIPKIcK188,200R or depletion of
PIPKIc impaired the adhesion strength of HCT116 cells on
fibronectin. (A) Expression of PIPKIcK188,200R inhibited HCT116 cells
adhering to low concentrations of fibronectin. The cells stably
expressing PIPKIc or PIPKIcK188,200R were incubated with Calcein-AM
and plated on a 96-well plate coated with fibronectin for centrifugation
assays. (B) Depletion of PIPKIc inhibited HCT116 cells adhering to
fibronectin. The cells that stably express control and PIPKIc shRNA
were incubated with Calcein-AM and plated on a 96-well plate coated
with fibronectin for centrifugation assays. Fa/F0 = (fluorescence after
centrifugation)4(fluorescence before centrifugation).
doi:10.1371/journal.pone.0024775.g006
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PIPKIc with Age1, blunting with Klenow, and digesting with Sal1.
The smaller fragments were sub-cloned into pBabe-neo vector that
had been treated with BamH1, Klenow, and Sal1. pBabe-ZZ-
PIPKIcRescue were created by PCR using pBabe-ZZ-PIPKIc as
template and sequentially 59-GGC ATC ATC GAC ATC CTG
CAA TCG TAC AGG TTC -39/59-GAA CCT GTA CGA TTG
CAG GAT GTC GAT GAT GCC -39 and 59- TCG TAC AGG
TTG ATA AAG AAA CTG GAG CAC ACC TG-39/59- CAG
GTG TGC TCC AGT TTC TTT ATC AAC CTG TAC GA-39
as primers. All plasmids were sequenced by Eurofins MWG
Operon (Huntsville, AL).
Cell culture, transfections and infections
CHO-K1 Chinese hamster ovary cells, HCT116 human colon
cancer cells and 293T human embryonic kidney cells were from
the American Type Culture Collection and were maintained in
DMEM medium (Mediatech, Inc.) containing 10% fetal bovine
serum (FBS), penicillin (100 U ml21) and streptomycin (100 mg
ml21). CHO-K1 cells were transfected with Safectine RU50 (Syd
Labs) according to the manufacturer’s protocol. HCT116 cells that
stably express EGFP-PIPKIc WT, or –PIPKIcK188, 200R, were
obtained by transfecting the cells with TurboFect (Fermentas) and
sorting EGFP-positive cells after G418 selection in the University
of Kentucky Flow Cytometry Facility, or by infecting with pBabe
retrovirus and selecting with puromycin. HCT116 cells stably
expressing shRNA control or PIPKIc shRNA were obtained by
infecting with pLKO1 lentivirus and selected with puromycin.
Preparation of viruses and cell infection
The 293T cells were transfected with pBabe retrovirus or pLKO1
lentivirus system using Safectine RU50 transfection reagent according
to the manufacturer’s protocol. The medium of transfectants was
collected at 48 and 72 h, filtered through 0.45-mm filter and
concentrated by ultracentrifugation. The virus particles were applied
to overnight cultures of HCT116 cells for infection. Cells stably
expressing recombinant proteins were obtained by growing infected
cells in the presence of 1 mg/ml puromycin for 10 days.
Immunofluorescence staining and TIRF imaging
Cells were plated on glass coverslips that were precoated with 5 mg/
ml fibronectin. For immunofluorescence staining, the cells were fixed
with 4% paraformaldehyde permeabilized with 0.5% Triton X-100,
Figure 7. Either depletion of PIPKIc or expression of PIPKIcK188,200R inhibited the invasion of HCT116 cells. (A) Depletion of PIPKIc by
using shRNA inhibited the invasion of HCT116 cells. The invasive capacities of cells stably expressing shRNA control or PIPKIc shRNA were examined
in the absence and presence of HGF (50 ng/ml) by Matrigel-based invasion assays. (B) Quantification of the invasion of HCT116 cells that stably
express shRNA control or PIPKIc shRNA. n = 5, error bar = mean 6 s.e.m; ctrl vs PIPKIc, p,0.01; ctrl HGF vs PIPKIc HGF, p,0.01. (C) Expression of
PIPKIcK188,200R inhibited the invasion of HCT116 cells. The cells that stably express EGFP-PIPKIc or –PIPKIcK188,200R were tested for invasive capacities in
the absence and presence of HGF. (D) Quantification of the invasion of HCT116 cells that stably express EGFP-PIPKIc or –PIPKIcK188,200R. n = 3, error
bar = mean 6 s.e.m; WT vs K188,200R, P,0.01; WT HGF vs K188,200R HGF, P,0.005.
doi:10.1371/journal.pone.0024775.g007
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Figure 8. PIPKIc is a major enzyme responsible for PIP2 and PIP3 production in HCT116 cells. Polyphosphoinositides from cells stably
expressing shRNA control or PIPKIc shRNA were extracted and derivatized using trimethylsilyl diazomethane, and then were measured using mass
spectrometry. N = 4, error bar = mean 6 s.e.m; PIP, P.0.05; PIP2, P = 0.0034; PIP3, P = 0.001.
doi:10.1371/journal.pone.0024775.g008
Figure 9. PIPKIc is required for vinculin localizing to focal adhesions in HCT116 cells. (A) Re-expression of rescue ZZ-tagged PIPKIc in cells
that PIPKIc has been knocked down (KD) by stably expressing PIPKIc shRNA. The PIPKIc-KD cells were infected with retroviral particles carrying rescue
ZZ-tagged PIPKIc selected with neomycin. ZZ-PIPKI was detected by Western blotting with an anti-PIPKIc polyclonal antibody. (B) TIRF images of
PIPKIc-KD cells and the KD cells that express rescue PIPKIc Cells were plated on glass-bottomed dishes pre-coated with fibronectin (5 mg/ml), fixed
and stained for vinculin. Scale bar, 20 mm. (C) PIPKIc rescue restored focal adhesion formation in PIPKIc-KD cells. (n = 11, error bar = mean 6 s.e.m;
paired t-test, P,0.0001) (D) Area distribution of focal adhesions in PIPKIc-KD cells and the KD cells expressing rescue PIPKIc.
doi:10.1371/journal.pone.0024775.g009
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blocked with 5% BSA in PBS, and then incubated with anti-paxillin
mAb. Paxillin was then visualized by incubating with DyLight
549 Conjugated goat Anti-mouse IgG (H+L). Paxillin staining and
EGFP fluorescence were viewed by using a Nikon Eclipse Ti TIRF
microscope equipped with a 606, 1.45 NA objective, CoolSNAP HQ2
CCD camera (Roper Scientific). Images were acquired and analyzed
by using NIS-Elements (Nikon). To quantify the number and area of
focal adhesions, paxillin immunofluorescence images were thresholded
to include only focal adhesions and the number and area were
calculated by using the software.
Time-lapse live fluorescence imaging
CHO-K1 cells that stably express EGFP-PIPKIc WT, or -
PIPKIcK188, 200R were transfected with mDsRed-paxillin. At 24 h
post-transfection, the cells were trypsinized and plated on MatTek
dishes (with a glass coverslip at the bottom) that had been
precoated with fibronectin (5 mg ml21). The cells were cultured for
3 hours and TIRF images were taken using the Nikon Eclipse Ti
TIRF microscope stated earlier and the temperature and humidity
were maintained by using a INU-TIZ-F1 microscope incubation
system (Tokai Hit). Images were recorded at 1-min intervals for a
120 min period. Focal adhesion assembly and disassembly rate
constants were analyzed as described previously [22].
PIPKIc activity assays
pZZ-PIPKIc and pZZ-PIPKIcK188,200R were transfected into
CHO-K1 cells. At 24 h post-transfection, the cells were harvested in
a lysis buffer (50 mM Tris-HCl, pH8.1, 140 mM NaCl, 50 mM
NaF, 1% Triton X-100, 10 mM 2-mercaptoethanol, 0.5 mM
AEBSF,10 mg/ml aprotinin, 10 mg/ml leupeptin, 5 mg/ml E-64,
5 mg/ml pepstatin, 5 mg/ml bebstatin,). Cell lysates were cleared by
centrifugation and pZZ-PIPKIc and pZZ-PIPKIcK188,200R in
supernatants were immuno-precipitated using IgG-Agarose beads.
The beads were washed three times with lysis buffer and washed
once with a kinase buffer (50 mM Tris-HCl, pH7.5, 5 mM MgCl2,
25 mM KCl, 0.5 mM EGTA, and 0.5 mM ATP). The beads were
incubated with 100 mL of the kinase buffer containing 100 mM
PI(4)P for 30 min at 37uC. PI(4,5)P2 formed in these assays was
extracted using modified Bligh-Dyer extraction [41]. Phosphoino-
sitides were quantitated using a Shimadzu UFLC coupled with an
ABI 4000-Qtrap hybrid linear ion trap triple quadrupole mass
spectrometer in multiple reaction monitoring (MRM) mode. 17:0–
20:4 PI(4)P, 17:0–20:4 PI(4,5)P2 and 17:0–20:4 PI(3,4,5)P3 (Avanti
Polar Lipids) were used as internal standards. PIP, PIP2 and PIP3s
were analyzed on an XTerra C8, 3.5 u, 3.06100 mm column.
Detailed experimental procedures are described in Materials S1.
Quantitation of Polyphosphoinositides in cells
Polyphosphoinositides were extracted using a modified Bligh-Dyer
extraction [41] and were derivatized using trimethylsilyl diazo-
methane as described [42]. Polyphosphoinositides were measured as
their TMS-diazomethane derivatives using a Shimadzu UFLC
equipped with a Vydac 214MS C4, 5 m, 4.66250 mm column,
coupled with an ABI 4000-Qtrap hybrid linear ion trap triple
quadrupole mass spectrometer in multiple reaction monitoring
(MRM) mode. 17:0–20:4 PI(4)P, 17:0–20:4 PI(4,5)P2 and 17:0–20:4
PI(3,4,5)P3 were used as internal standards. Detailed experimental
procedures are described in Materials S1.
Centrifugation assays
HCT116 cells growing on 60-mm dishes were incubated in 2 ml
of 2 mg/ml calcein-AM in opti-MEM for 20 min at 37uC. The
Cells were then trypsinized, washed and re-suspended in normal
growth media containing 10%FBS. The cell suspensions (100 ml,
40,000 cells/well) were added to a 96-well plate coated with
different concentrations of fibronectin, centrifuged at 180g in a
Beckman Coulter Allegra X-15R centrifuge (SX4750A rotor) and
allowed to attach for 1h in 37uC CO2 incubator. Each well was
then carefully aspirated to remove floating cells and refilled with
fresh PBS-dextrose. An initial fluorescence (F0) was read to
determine the density of cells before detachment using a Promega
Glomax multi+ Detection system (490 nm excitation, 510–570 nm
emission). The lid was then removed, and the plate was covered
with sealing tape and centrifuged upside down at 150 g for 5 min
to detach the cells. The wells were carefully aspirated and refilled
with fresh PBS-dextrose. The fluorescence after centrifuging (Fa)
was read to determine the density of cells that remain attached.
Invasion Assays
One hundred microliters of Matrigel (1:30 dilution in serum-
free DMEM medium) was added to each Transwell polycarbonate
filter (6 mm diameter, 8 mm pore size, Costar) and incubated with
the filters at 37uC for 4 h. HCT116 cells were trypsinized and
washed 3 times with DMEM containing 1% FBS. The cells were
resuspended in DMEM containing 1% FBS at a density of 16106
cells/ml. The cell suspensions (100 ml) were seeded into the upper
chambers, and 600 ml of DMEM medium containing 1% FBS and
5 mg/ml Fibronectin with or without 50 ng/ml HGF were added
to the lower chambers. The cells were allowed to invade for 36 h
in a CO2 incubator. The invaded cells were fixed for 15 min with
3.7% formaldehyde and stained using 0.1% crystal violet in 10%
ethanol for 30 min. The number of invaded cells per field was
counted under a light microscope at 6200.
Supporting Information
Figure S1 PIPKIcD316K, a kinase-dead mutant, was
unable to promote focal adhesion formation in CHO-
K1 cells. (A) TIRF images of CHO-K1 cells expressing PIPKIc
or PIPKIcD316K. Cells were transiently transfected with pEGFP-
PIPKIc WT or –PIPKIcD316K, and then stained for paxillin. Scale
bar, 20 mm. (B) PIPKIcD316K was deficient in promoting an
increase in focal adhesion number (n = 10, error bar = mean 6
s.e.m; P,0.005). (C) Area distribution of focal adhesions in cells
expressing PIPKIc and PIPKIcD316K.
(TIF)
Figure S2 Neither expression of PIPKIcK188,200R nor
depletion of PIPKIc impaired the migration of HCT116
cells. (A) Expression of PIPKIcK188,200R slightly enhanced the
migration of HCT116 cells. The cells that stably express EGFP-
PIPKIc or –PIPKIcK188,200R were plated on 35 mm MatTek glass
bottom dishes coated with 5 mg/ml fibronectin, and grown to 90%
confluency. The medium was then changed to DMEM containing
1%FBS and 10 ng/ml HGF for 6 h. A wound was made on the
confluent monolayer, and time-lapse cell migration was recorded
using a Nikon Biostation IMQ. The pictures were extracted from
time-lapse movies. (B) Quantification of the migration speed of
HCT116 cells that stably express PIPKIc or PIPKIcK188,200R
using NIS-Elements AR 3.2. (n = 4, *P,0.05). (C) Depletion of
PIPKIc by using shRNA had no significant effect on the migration
of HCT116 cells. The migration of cells stably expressing shRNA
control or PIPKIc shRNA were examined in the absence and
presence of HGF (50 ng/ml) by Transwell migration assays. In
brief, transwell polycarbonate filters (6 mm diameter, 8 mm pore
size, Costar) were coated with fibronectin (5 mg/ml) over night.
HCT116 cells were trypsinized and washed 3 times with DMEM
containing 1% FBS. The cells were resuspended in DMEM
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containing 1% FBS at a density of 16106 cells/ml. The cell
suspensions (100 ml) were seeded into the upper chambers, and
600 ml of DMEM medium containing 1% FBS and 5 mg/ml
Fibronectin with or without 50 ng/ml HGF were added to the
lower chambers. The cells were allowed to migrate for 24 h in a
CO2 incubator. The migrated cells were fixed for 15 min with
3.7% formaldehyde and stained using 0.1% crystal violet in 10%
ethanol for 30 min. The number of migrated cells per membrane
was counted under a light microscope at6200. (D) Quantification
of the migration of HCT116 cells that stably express shRNA
control or PIPKIc shRNA. n = 3, error bar = mean 6 s.e.m,
P.0.05.
(TIF)
Materials S1 Quantitation of phosphoinositides by
HPLC ESI tandem Mass Spectrometry.
(DOCX)
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